Conclusions
Obesity is associated with OSAS and disruptions in sleep duration and quality. The reader is referred to two articles in this issue, “Epidemiology of sleep in relation to obesity, insulin resistance, and metabolic syndrome” and “Sleep influences on obesity, insulin resistance, and metabolic syndrome” for closer examination. Initial lifestyle, pharmacological and surgical therapy studies suggest that weight loss is associated with improvements in OSAS, sleep duration, and sleep quality, although with a high degree of variability in improvements observed. More research is needed to assess long-term effects of weight loss, as well as mechanisms of action, by different weight loss modalities on OSAS, insomnia, sleep duration, and sleep quality. Currently, long-term studies are promising with greater response for OSAS with those who maintain weight loss, especially in the pediatric population, who may experience significant long-term health benefits. Given our current knowledge, weight reduction should always be encouraged for people living with obesity, OSAS, and/or sleep disruptions and resources identified to assist patients in choosing a weight loss approach that will benefit them the most.